Congress is doing this because they want to restrict contraception and ban abortion. We have proof.” Amy Friedrich-Karnik, Guttmacher’s Director of Federal Policy, revisited comments she made at a Senate press conference in June. At the time, federal lawmakers were weighing drastic cuts to Medicaid—the health insurance program that includes coverage of a robust package of contraceptive services—and many grantees of the Title X family planning program had seen their funding withheld. That proof came from a study Guttmacher began in 2016, tracking the impact of the most sweeping disruptions to US contraceptive access in 50 years, including the 2019 Title X “domestic gag rule,” the COVID-19 pandemic and the Dobbs v. Jackson Women’s Health Organization decision overturning federal abortion rights.
Guttmacher’s Reproductive Health Impact Study (RHIS) zeroed in on four states: Arizona, Iowa, New Jersey and Wisconsin. It was particularly ambitious in scope, tracking patients’ experiences seeking contraceptive and related care over a seven-year period. That long time horizon allowed researchers to understand the impact of state and federal policy changes during the first Trump administration, which included a drastic reduction in the number of clinics receiving funding for services for low-income people.